Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.8 USD | +4.50% | -2.12% | +19.90% |
May. 17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
May. 13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.90% | 177M | |
+10.48% | 114B | |
+10.94% | 105B | |
-5.53% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-16.21% | 16.13B | |
+2.34% | 13.75B | |
+31.55% | 11.76B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024